Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients
The DOI matches its Crossref record; 31 of the 33 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-1 beta, IL-6, epidermal growth factor (EGF), and transforming growth factor-alpha (TGF-alpha) were measured for the first time in the brain (caudate nucleus, putamen and cerebral cortex) from control and parkinsonian patients by highly sensitive sandwich enzyme immunoassays. The concentrations of IL-1 beta, IL-6, EGF, and TGF-alpha in the dopaminergic, striatal regions were significantly higher in parkinsonian patients than those in controls, whereas those in the cerebral cortex did not show significant differences between parkinsonian and control subjects. Since these cytokines and growth factors may play important roles as neurotrophic factors in the brain, the present results suggest that they may be produced as compensatory responses in the nigrostriatal dopaminergic regions in Parkinson's disease, and may be related, at least in part, to the process of neurodegeneration in Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, increased levels of inflammatory cytokines including interleukin 1-beta (IL-1β), interleukin-6 (IL-6), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α) have been found within brain parenchyma and human cerebrospinal fluid (CSF) of PD patients [7–9].”
From Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice (2019) · cites this paper as [7]
In the citing paper
“IL-1β levels have been reported to be elevated in the CSF [218], serum [222] and dopaminergic regions of the striatum from patients with PD compared to controls [253].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [253]
In the citing paper
“IL-6 levels have also been found elevated in the striatal dopaminergic region [253], as well as the CSF from PD patients compared to controls [218].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [253]
In the citing paper
“Increased IL-1β and caspase-1 have been measured in the serum and the striatum of PD patients (237).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [237]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,909
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve
Lindholm, D., Heumann, R., Meyer, M., & Thoenen, H. (1987) · Nature · doi:10.1038/330658a0 · Cited by 994
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Self-citationTodaro, G. J., Fryling, C., & De Larco, J. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5258 · Cited by 893
Interleukin-1 Stimulation of Astroglial Proliferation After Brain Injury
Giulian, D., & Lachman, L. B. (1985) · Science · doi:10.1126/science.3872478 · Cited by 855
TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION: A COMMON MEDIATOR
Beutler, B., & Cerami, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002445 · Cited by 813
Fontana, A., Kristensen, F., Dubs, R., Gemsa, D., & Weber, E. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.6.2413 · Cited by 752
Derynck, R. (1988) · Cell · doi:10.1016/s0092-8674(88)80001-1 · Cited by 694
Cited by
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Metadata
- Authors
- Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T.
- Affiliations
- Matsumoto Dental University (JP)
- Juntendo University (JP)
- University of Würzburg (DE)
- Nippon Medical School (JP)
- Fujita Health University (JP)
- Corresponding author
- Nagatsu, Toshiharu
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 1994-10
- Volume
- 180
- Issue
- 2
- Pages
- 147-150
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W1966918485
- Cited by
- 855
- References
- 33
- Citations by year
- 2026: 17 · 2025: 33 · 2024: 36 · 2023: 40 · 2022: 60 · 2021: 51 · 2020: 53 · 2019: 37 · 2018: 44 · 2017: 31 · 2016: 42 · 2015: 36 · 2014: 36 · 2013: 33 · 2012: 30
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, IL-1β, interleukin-6, epidermal growth factor, transforming growth factor-alpha, cytokines, growth factors, neurotrophic factors, nigrostriatal pathway, caudate nucleus, putamen, cerebral cortex, neurodegeneration, compensatory response
- MeSH terms
- Aged, Aged, 80 and over, Brain Chemistry, Caudate Nucleus, Cerebral Cortex, Dopamine, Enzyme-Linked Immunosorbent Assay, Epidermal Growth Factor, Female, Humans, Interleukin-1, Male, Middle Aged, Nerve Tissue Proteins, Parkinson Disease, Putamen, Interleukin-6, Transforming Growth Factor alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. https://app.cochat.ai/papers/10.1016/0304-3940(94)90508-8
- The paper
- Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994). Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neuroscience Letters. https://doi.org/10.1016/0304-3940(94)90508-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.